Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

J.A.C.M. Goos; A.C. Hiemstra; V.M.H. Coupe; B. Diosdado; W. Kooijman; P.M. van Diemen; C. Karga; J.A.M. Belien; C.W.M. van Oordt; A.A. Geldof; G.A. Meijer; O.S. Hoekstra; R.J.A. Fijneman

doi:https://doi.org/10.1038/bjc.2014.354

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

J.A.C.M. Goos, A.C. Hiemstra, V.M.H. Coupe, B. Diosdado, W. Kooijman, P.M. van Diemen, C. Karga, J.A.M. Belien, C.W.M. van Oordt, A.A. Geldof, G.A. Meijer, O.S. Hoekstra, R.J.A. Fijneman

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	749-755
Journal	British journal of cancer
Volume	111
Issue number	4
DOIs	https://doi.org/10.1038/bjc.2014.354
Publication status	Published - 2014

Access to Document

https://doi.org/10.1038/bjc.2014.354

Cite this

Goos, J. A. C. M., Hiemstra, A. C., Coupe, V. M. H., Diosdado, B., Kooijman, W., van Diemen, P. M., Karga, C., Belien, J. A. M., van Oordt, C. W. M., Geldof, A. A., Meijer, G. A., Hoekstra, O. S., & Fijneman, R. J. A. (2014). Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases. British journal of cancer, 111(4), 749-755. https://doi.org/10.1038/bjc.2014.354

@article{3aee74ea45224f35a6dcefff48be6ff9,

title = "Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases",

author = "J.A.C.M. Goos and A.C. Hiemstra and V.M.H. Coupe and B. Diosdado and W. Kooijman and {van Diemen}, P.M. and C. Karga and J.A.M. Belien and {van Oordt}, C.W.M. and A.A. Geldof and G.A. Meijer and O.S. Hoekstra and R.J.A. Fijneman",

year = "2014",

doi = "https://doi.org/10.1038/bjc.2014.354",

language = "Undefined/Unknown",

volume = "111",

pages = "749--755",

journal = "British journal of cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "4",

}

Goos, JACM, Hiemstra, AC, Coupe, VMH, Diosdado, B, Kooijman, W, van Diemen, PM, Karga, C, Belien, JAM, van Oordt, CWM, Geldof, AA, Meijer, GA, Hoekstra, OS & Fijneman, RJA 2014, 'Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases', British journal of cancer, vol. 111, no. 4, pp. 749-755. https://doi.org/10.1038/bjc.2014.354

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases. / Goos, J.A.C.M.; Hiemstra, A.C.; Coupe, V.M.H. et al.
In: British journal of cancer, Vol. 111, No. 4, 2014, p. 749-755.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

AU - Goos, J.A.C.M.

AU - Hiemstra, A.C.

AU - Coupe, V.M.H.

AU - Diosdado, B.

AU - Kooijman, W.

AU - van Diemen, P.M.

AU - Karga, C.

AU - Belien, J.A.M.

AU - van Oordt, C.W.M.

AU - Geldof, A.A.

AU - Meijer, G.A.

AU - Hoekstra, O.S.

AU - Fijneman, R.J.A.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1038/bjc.2014.354

DO - https://doi.org/10.1038/bjc.2014.354

M3 - Article

C2 - 24983372

SN - 0007-0920

VL - 111

SP - 749

EP - 755

JO - British journal of cancer

JF - British journal of cancer

IS - 4

ER -